Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Neuropharmacology ; 52(6): 1366-77, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17397881

RESUMO

In the current study, we have evaluated the ability of substance P (SP) and other neurokinin 1 receptor (NK1) agonists to protect, in a dose- and time-dependent manner, primary cultures of rat cerebellar granule cells (CGCs) from serum and potassium deprivation-induced cell death (S-K5). We also established the presence of SP high affinity NK1 transcripts and the NK1 protein localization in the membrane of a sub-population of CGCs. Moreover, SP significantly and dose-dependently reduced the Akt 1/2 and Erk1/2 dephosphorylation induced by S-K5 conditions, as demonstrated by Western blot analysis. Surprisingly, in SP-treated CGCs caspase-3 activity was not inhibited, while the calpain-1 activity was moderately reduced. Corroborating this result, SP blocked calpain-mediated cleavage of tau protein, as demonstrated by the reduced appearance of a diagnostic fragment of 17 kDa by Western blot analysis. In addition, SP induced a significant reduction of the delayed rectifier K+ currents (Ik) in about 42% of the patched neurons, when these were evoked with depolarizing potential steps. Taken together, the present results demonstrate that the activation of NK1 receptors expressed in CGCs promote the neuronal survival via pathways involving Akt and Erk activation and by inhibition of Ik which can contribute to the neuroprotective effect of the peptide.


Assuntos
Cerebelo/efeitos dos fármacos , Canais de Potássio de Retificação Tardia/fisiologia , MAP Quinases Reguladas por Sinal Extracelular/fisiologia , Proteínas Quinases Ativadas por Mitógeno/fisiologia , Fármacos Neuroprotetores , Substância P/farmacologia , Animais , Western Blotting , Calpaína/antagonistas & inibidores , Caspases/metabolismo , Cerebelo/citologia , Grânulos Citoplasmáticos/fisiologia , Canais de Potássio de Retificação Tardia/efeitos dos fármacos , Eletrofisiologia , Ativação Enzimática/efeitos dos fármacos , Imuno-Histoquímica , Microscopia de Contraste de Fase , Proteína Oncogênica v-akt/fisiologia , Técnicas de Patch-Clamp , Potássio/fisiologia , Ratos , Ratos Wistar , Receptores da Neurocinina-1/efeitos dos fármacos , Receptores da Neurocinina-1/fisiologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Substância P/análogos & derivados , Taquicininas/agonistas
2.
Neuropharmacology ; 58(1): 268-76, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19576909

RESUMO

The tachykinin endecapeptide substance P (SP) has been demonstrated to exert a functional role in neurodegenerative disorders, including Alzheimer's disease (AD). Aim of the present study was to evaluate the SP neuroprotective potential against apoptosis induced by the neurotoxic beta-amyloid peptide (A beta) in cultured rat cerebellar granule cells (CGCs). We found that SP protects CGCs against both A beta(25-35)- and A beta(1-42)-induced apoptotic CGCs death as revealed by live/dead cell assay, Hoechst staining and caspase(s)-induced PARP-1 cleavage, through an Akt-dependent mechanism. Since in CGCs the fast inactivating or A-type K(+) current (I(KA)) was potentiated by A beta treatment through up-regulation of Kv4 subunits, we investigated whether I(KA) and the related potassium channel subunits could be involved in the SP anti-apoptotic activity. Patch-clamp experiments showed that the A beta-induced increase of I(KA) current amplitude was reversed by SP treatment. In addition, as revealed by Western blot analysis and immunofluorescence studies, SP prevented the up-regulation of Kv4.2 and Kv4.3 channel subunits expression. These results indicate that SP plays a role in the regulation of voltage-gated potassium channels in A beta-mediated neuronal death and may represent a new approach in the understanding and treatment of AD.


Assuntos
Peptídeos beta-Amiloides/farmacologia , Cerebelo/citologia , Neurônios/efeitos dos fármacos , Canais de Potássio Shal/metabolismo , Substância P/farmacologia , Animais , Animais Recém-Nascidos , Biofísica , Caspase 3/metabolismo , Células Cultivadas , Estimulação Elétrica , Ativação do Canal Iônico/efeitos dos fármacos , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/fisiologia , Proteína Oncogênica v-akt/metabolismo , Técnicas de Patch-Clamp/métodos , Fragmentos de Peptídeos/farmacologia , Fosforilação/efeitos dos fármacos , Ratos , Ratos Wistar , Canais de Potássio Shal/efeitos dos fármacos
3.
Genes Brain Behav ; 7(4): 427-34, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18081837

RESUMO

Amyotrophic lateral sclerosis (ALS) is a fatal progressive neuropathy associated with the degeneration of spinal and brainstem motor neurons. Although ALS is essentially considered as a lower motor neuron disease, prefrontal cortex atrophy underlying executive function deficits have been extensively reported in ALS patients. Here, we examine whether prefrontal cortex neuronal abnormalities and related cognitive impairments are present in presymptomatic G93A Cu/Zn superoxide dismutase mice, a mouse model for familial ALS. Structural characteristics of prelimbic/infralimbic (PL/IL) medial prefrontal cortex (mPFC) neurons were studied in 3-month-old G93A and wild-type mice with the Golgi-Cox method, while mPFC-related cognitive operations were assessed using the conditioned fear extinction paradigm. Sholl analysis performed on the dendritic material showed a reduction in dendrite length and branch nodes on basal dendrites of PL/IL neurons in G93A mice. Spine density was also decreased on basal dendrite segments of branch order five. Consistent with the altered morphology of PL/IL cortical regions, G93A mice showed impaired extinction of conditioned fear. Our findings indicate that abnormal prefrontal cortex connectivity and function are appreciable before the onset of motor disturbances in this model.


Assuntos
Esclerose Lateral Amiotrófica/genética , Esclerose Lateral Amiotrófica/psicologia , Transtornos Cognitivos/genética , Extinção Psicológica/fisiologia , Córtex Pré-Frontal/anormalidades , Superóxido Dismutase/genética , Esclerose Lateral Amiotrófica/complicações , Animais , Forma Celular/genética , Transtornos Cognitivos/enzimologia , Transtornos Cognitivos/fisiopatologia , Condicionamento Psicológico/fisiologia , Espinhas Dendríticas/patologia , Modelos Animais de Doenças , Progressão da Doença , Medo/fisiologia , Predisposição Genética para Doença , Humanos , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Mutação/genética , Malformações do Sistema Nervoso/enzimologia , Malformações do Sistema Nervoso/genética , Malformações do Sistema Nervoso/fisiopatologia , Vias Neurais/anormalidades , Vias Neurais/enzimologia , Vias Neurais/fisiopatologia , Córtex Pré-Frontal/enzimologia , Córtex Pré-Frontal/fisiopatologia , Células Piramidais/patologia , Coloração pela Prata
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA